WO2022224206 - METHOD FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN SPECIFIC PATIENTS USING MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS
National phase entry:
Publication Number
WO/2022/224206
Publication Date
27.10.2022
International Application No.
PCT/IB2022/053762
International Filing Date
22.04.2022
Title **
[English]
METHOD FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN SPECIFIC PATIENTS USING MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS
[French]
PROCÉDÉ DE TRAITEMENT DU SYNDROME DE DÉTRESSE RESPIRATOIRE AIGUË (SDRA) CHEZ DES PATIENTS SPÉCIFIQUES À L'AIDE DE CELLULES SOUCHES OU PRÉCURSEURS DE LA LIGNÉE MÉSENCHYMATEUSE
Applicants **
MESOBLAST INTERNATIONAL SARL
C/- Accounting and Management Services SA
Route de Pre-Bois 20
1217 Meyrin, CH
Inventors
ITESCU, Silviu
C/- Level 38
55 Collins Street
Melbourne, Victoria 3000, AU
Priority Data
2021901214
23.04.2021
AU
2021902180
15.07.2021
AU
2022900260
09.02.2022
AU
2022900372
18.02.2022
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2554 | |
| EPO | Filing, Examination | 18144 | |
| Japan | Filing | 588 | |
| South Korea | Filing | 671 | |
| USA | Filing, Examination | 9710 |
Total: 31667 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates to methods for treating or preventing Acute Respiratory Distress Syndrome (ARDS) in a subject in need thereof, the method comprising administering to the subject a composition comprising mesenchymal lineage precursor or stem cells (MLPSCs).[French]
La présente divulgation concerne un procédé de traitement ou de prévention du syndrome de détresse respiratoire aiguë (SDRA) chez un sujet en ayant besoin, ce procédé comprenant l'administration au sujet d'une composition comprenant des cellules souches ou précurseurs de la lignée mésenchymateuse (MLPSC).